The US Food and Drug Administration (FDA) on Friday approved a new drug that appears to slow the progression of Alzheimer's disease, according to Anadolu Agency. The FDA said Leqembi known chemically as lecanemab
WASHINGTON U.S. health officials on Friday approved a closely watched Alzheimer s drug that modestly slows the brain-robbing disease, albeit with potential safety risks that patients and their doctors will have to carefully weigh.
U.S. health officials on Friday approved a closely watched Alzheimer's drug that's been shown to modestly slow the early stages of the brain-robbing disease, albeit with potential safety risks that doctors and patients will have to weigh carefully. The drug, Leqembi, is the first that's been convincingly shown to slow the decline in memory and…